Next report date
Report period
Q1 2024
EPS estimate
6.70TWD
Revenue estimate
3.13 BTWD
30TWD
3.03 BTWD
14.20 BTWD
60.66 M
About BORA PHARMACEUTICALS CO LTD
Sector
CEO
Pao Hsi Sheng
Headquarters
Taipei
Website
Founded
2007
ISIN
TW0006472004
FIGI
BBG0076JFSF2
Bora Pharmaceuticals Co., Ltd. engages in the manufacturing and sales of generic, brand, and over-the-counter drugs. Its products include central nervous system medication, cardiovascular medicine, antibiotics, antivirals, ophthalmic, antipsychotics, dementia drugs, sleeping agents, lowering blood pressure drugs, and health food. The firm operates through the following segments: Sales, Manufacturing, and Other Segment. The Sales segment comprises of the pharmaceuticals and healthcare products. The Manufacturing segment consists of Contract development & manufacturing organization of pharmaceuticals. The Other Segment refers to the distributing and developing pharmaceuticals. Bora Pharmaceuticals was founded on June 12, 2007 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6472 is 772 TWD — it has decreased by 1.40% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange BORA PHARMACEUTICALS CO LTD stocks are traded under the ticker 6472.
BORA PHARMACEUTICALS CO LTD is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
6472 stock is 1.82% volatile and has beta coefficient of −0.15. Check out the list of the most volatile stocks — is BORA PHARMACEUTICALS CO LTD there?
BORA PHARMACEUTICALS CO LTD revenue for the last quarter amounts to 3.08 B TWD despite the estimated figure of 3.11 B TWD. In the next quarter revenue is expected to reach 3.19 B TWD.
Yes, you can track BORA PHARMACEUTICALS CO LTD financials in yearly and quarterly reports right on TradingView.
6472 stock has risen by 5.75% compared to the previous week, the month change is a 17.50% rise, over the last year BORA PHARMACEUTICALS CO LTD has showed a 13.03% increase.
6472 net income for the last quarter is 565.61 M TWD, while the quarter before that showed 733.17 M TWD of net income which accounts for −22.85% change. Track more BORA PHARMACEUTICALS CO LTD financial stats to get the full picture.
Today BORA PHARMACEUTICALS CO LTD has the market capitalization of 76.10 B, it has decreased by 6.87% over the last week.
Yes, 6472 dividends are paid annually. The last dividend per share was 8.00 TWD. As of today, Dividend Yield (TTM)% is 0.82%. Tracking BORA PHARMACEUTICALS CO LTD dividends might help you take more informed decisions.
BORA PHARMACEUTICALS CO LTD dividend yield was 1.88% in 2023, and payout ratio reached 39.74%. The year before the numbers were 1.93% and 43.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 6472 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BORA PHARMACEUTICALS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on BORA PHARMACEUTICALS CO LTD future price: according to them, 6472 price has a max estimate of 992.00 TWD and a min estimate of 783.00 TWD. Read a more detailed BORA PHARMACEUTICALS CO LTD forecast: see what analysts think of BORA PHARMACEUTICALS CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BORA PHARMACEUTICALS CO LTD EBITDA is 5.86 B TWD, and current EBITDA margin is 41.24%. See more stats in BORA PHARMACEUTICALS CO LTD financial statements.